TrialsgrambetaRCTs are beautiful

FAME 3

2022

Fractional flow reserve versus Angiography for Multivessel Evaluation 3

In 1,500 patients with 3-vessel coronary disease, FFR-guided PCI did not prove non-inferior for 1-year death, MI, stroke, or repeat revascularisation compared with CABG.

Result

Efficacy: MACCE (death, MI, stroke, or repeat revascularisation) at 1 yearHR 1.5 (95% CI 1.1-2.2)

Below 1 favours FFR-guided PCI, above 1 favours CABG.

Event rates
Absolute difference
3.7 points
NNH
28

Absolute difference and NNH are derived from the event rates.

Also reported: Non-inferiority not met. At 5 years death/stroke/MI similar (16% vs 14%, HR 1.16, 95% CI 0.89-1.52).

Original publication
Subtopic
FFR-guided PCI
Design
Multicentre RCT, non-inferiority
Relevance
Important: one of several pillars.
Cited in
ESC 2024 CCS
Source
Fearon WF, et al. N Engl J Med. 2022;386(2):128-37.doi 10.1056/NEJMoa2112299

Discussion & critique

1-year timepoint is short for a surgery-vs-PCI comparison and differences narrowed by 5 years. Reinforced CABG as preferred for higher-complexity 3-vessel disease while supporting PCI in lower SYNTAX-score anatomy.

Discussed in podcasts